tirzepatide equivalent dose semaglutide Switching from to conversion Evaluating Dose Titration in Semaglutide
Description
Conclusion In this small retrospective cohort of patients with ESRD, semaglutide use was associated with descriptive changes in glycemic parameters, body weight, and clinical outcomes over prolonged follow-up

PMID: 33 SharmaANBauerIESanchesMGalvezJFZunta-SoaresGBQuevedoJet al

Your provider should evaluate your specific GI history before authorizing concurrent use

The label notes, In Zepbound clinical trials, hair loss was reported more frequently in female than male patients in the Zepbound (7.1% female versus 0.5% male) and placebo (1.3% female versus 0% male) treatment groups. Treatments for hair loss Experts say telogen effluvium with GLP-1 use is typically temporary, but people who develop hair loss should seek medical evaluation

This compensation does not influence the factual accuracy of the information presented

This is just to help your body get used to the medicine, it's not the dose that will actually treat your condition
